Smith & Nephew Plc
01 October 2007
SMITH & NEPHEW ADVANCED WOUND MANAGEMENT APPOINTS PAUL CAMPBELL AS VICE
PRESIDENT OF STRATEGIC MARKETING
Hull, ENG. and Largo, FL, October 1, 2007 -Smith & Nephew's (LSE: SN; NYSE:SNN)
Advanced Wound Management division today announced the appointment of Paul
Campbell as Vice President of Strategic Marketing for its Advanced Wound Care
Strategic Business Unit (SBU).
Campbell joins Smith & Nephew from J&J Medical, where he commenced
his career in regional Territory Management and Marketing Management roles for
ETHICON Sutures followed by a Product Director role, a Franchise Manager role,
European Business Manager for Haemostasis products and latterly as Group
Marketing Director Worldwide for Surgical Meshes. These roles spanned various
geographies, and he has lived and worked in France, Israel, Turkey, the US as
well as the UK.
'Paul has worked in the medical device industry for the last 18 years with
particular focus in Sales and Marketing. In that time he has gained a broad
range of international experience and has demonstrated success in a number of
senior management positions', commented Roger Teasdale Senior Vice President.
In this role Campbell will report to Roger Teasdale, Senior Vice President of
the Advanced Wound Care SBU.
Campbell holds a Masters in Languages and an MBA from the University of
Edinburgh.
FOR IMMEDIATE RELEASE
Contact: Sidonie Myers
Smith & Nephew Advanced Wound Management
+ 44 1482 673246
About Smith & Nephew:
Smith & Nephew is a global medical technology business, specialising in
Orthopaedic Reconstruction, Orthopaedic Trauma and Clinical Therapies, Endoscopy
and Advanced Wound Management products. Smith & Nephew is a global leader in
arthroscopy and advanced wound management and is one of the leading global
orthopaedics companies.
Smith & Nephew is dedicated to helping improve people's lives. The Company
prides itself on the strength of its relationships with its surgeons and
professional healthcare customers, with whom its name is synonymous with high
standards of performance, innovation and trust. The Company has 9,600 employees
and operates in 31 countries around the world. Annual sales in 2006 were nearly
$2.8 billion.
###
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.